# Unravelling Intestinal Fibrosis in Ulcerative Colitis

> **NCT06604273** · PHASE2,PHASE3 · RECRUITING · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 10 (estimated)

## Conditions studied

- Ulcerative Colitis (UC)
- Inflammatory Bowel Disease (IBD)
- Fibroblast Activation Protein Inhibitor

## Interventions

- **DIAGNOSTIC_TEST:** Fibroblast Activation Protein Inhibitor

## Key facts

- **NCT ID:** NCT06604273
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-03
- **Primary completion:** 2025-10-03
- **Final completion:** 2026-04-03
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06604273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06604273, "Unravelling Intestinal Fibrosis in Ulcerative Colitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06604273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*